ClinConnect ClinConnect Logo
Search / Trial NCT05300893

Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture

Launched by UPPSALA UNIVERSITY · Mar 17, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Percutaneous Needle Fasciotomy Splint

ClinConnect Summary

This clinical trial is studying whether wearing a night splint after a specific treatment called percutaneous needle fasciotomy (PNF) can help reduce the chances of Dupuytren's contracture (DC) coming back. Dupuytren's contracture is a condition where the fingers bend towards the palm due to thickening of the tissue in the hand. The trial will involve patients who are 18 years or older and have specific signs of DC, such as a noticeable tightening in one or two fingers. However, those with more severe cases or prior treatments for the same finger will not be eligible to participate.

Participants in the study will be divided into two groups. One group will receive standard treatment, which includes physical therapy and night splinting, while the other group will have physical therapy without the night splint. Throughout the study, researchers will check how well each participant's hand is functioning, including how much they can move their fingers and their grip strength, at different times—starting from the day of the procedure and continuing for up to three years. This trial is important because it aims to provide clearer answers about whether night splinting is helpful after PNF treatment, which can guide future care for those with Dupuytren's contracture.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age and older,
  • Palpable Dupuytren strand with passive extension deficit according to stadium 1 and 2 of the classification of Tubiana in one or two fingers excluding the thumb, defined as at least 30 degrees in the MCP joint and/or at least 20 degrees in the PIP joint and a maximum of 75 degrees in the MCP or PIP joint
  • Exclusion Criteria:
  • Multiple, invasive or wide strands in the palm,
  • Skin irritation,
  • Strand localization in the digit only,
  • Digital nerve injury,
  • Any former treatment for Dupuytren's contracture in the same digit,
  • Thumb contracture,
  • Stadium 3 and 4 according to the classification of Tubiana

About Uppsala University

Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.

Locations

Uppsala, , Sweden

örebro, , Sweden

Falun, Dalarna, Sweden

örebro, örebro Län, Sweden

Uppsala, Uppsala Län, Sweden

Patients applied

0 patients applied

Trial Officials

Stephan Wilbrand, MD, PhD

Principal Investigator

Uppsala University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials